✦ LIBER ✦

Cost–effectiveness of natalizumab in multiple sclerosis: an updated systematic review

✍ Scribed by Koeser, Leonardo; McCrone, Paul

Book ID: 120370234
Publisher: Expert Reviews
Year: 2013
Tongue: English
Weight: 398 KB
Volume: 13
Category: Article
ISSN: 1473-7167
DOI: 10.1586/erp.13.14

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PND9 THE COST-EFFECTIVENESS OF NATALIZUM

PND9 THE COST-EFFECTIVENESS OF NATALIZUMAB IN PATIENTS WITH RELAPSING MULTIPLE SCLEROSIS

✍ K Meyer; E Chiao 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 68 KB

Cochrane Database of Systematic Reviews

Cochrane Database of Systematic Reviews (Reviews) || Natalizumab for relapsing remitting multiple sclerosis

✍ Pucci, Eugenio 📂 Article 📅 2011 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 747 KB

Epigenetics of Multiple Sclerosis: An Up

Epigenetics of Multiple Sclerosis: An Updated Review

✍ Küçükali, Cem İsmail; Kürtüncü, Murat; Çoban, Arzu; Çebi, Merve; Tüzün, Erdem 📂 Article 📅 2014 🏛 Humana Press Inc 🌐 English ⚖ 458 KB

Cost effectiveness and budget impact of

Cost effectiveness and budget impact of natalizumab in patients with relapsing multiple sclerosis

✍ Chiao, Evelyn; Meyer, Kellie 📂 Article 📅 2009 🏛 Informa plc 🌐 English ⚖ 170 KB

Cost-effectiveness of natalizumab versus

Cost-effectiveness of natalizumab versus fingolimod for the treatment of relapsing multiple sclerosis

✍ O’Day, Ken; Meyer, Kellie; Miller, Ross M.; Agarwal, Sonalee; Franklin, Meg 📂 Article 📅 2011 🏛 Informa plc 🌐 English ⚖ 373 KB

Cost-Effectiveness Analyses in Multiple

Cost-Effectiveness Analyses in Multiple Sclerosis: A Review of Modelling Approaches

✍ Guo, Shien; Pelligra, Christopher; Saint-Laurent Thibault, Catherine; Hernandez, 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 598 KB